Research Topics
Species | Christopher M BlanchetteSummaryAffiliation: Lovelace Respiratory Research Institute Country: USA Publications
| Collaborators
|
Detail Information
Publications
Burden of blood transfusion in knee and hip surgery in the US and BelgiumChristopher M Blanchette
Lovelace Respiratory Research Institute, Albuquerque, NM, USA
J Med Econ 12:171-9. 2009..The objective of this study was to assess treatments and costs associated with blood and blood product transfusions in a historical cohort of 189,457 inpatients in the US and 34,987 inpatients in Belgium undergoing knee or hip surgery...- Health care use in depressed, elderly, cardiac patients and the effect of antidepressant useChristopher M Blanchette
Center for Pharmacoeconomics and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC 28081, USA
Am J Health Syst Pharm 66:366-72. 2009..The association between a diagnosis of depression after a thromboembolic event (TEE) and an increase in acute health care use was examined... - Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older Christopher M Blanchette
Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, New Mexico 87108, USA
Am J Geriatr Pharmacother 6:138-46. 2008..Cost-effective treatments for chronic obstructive pulmonary disease (COPD) are needed to reduce the burden on the Medicare system... - Advances in chronic obstructive pulmonary disease among older adultsChristopher M Blanchette
Lovelace Respiratory Research Institute, Kannapolis, NC, USA
Curr Opin Pulm Med 17:84-9. 2011..This review summarizes recent research on chronic obstructive pulmonary disease (COPD) among older adults... 
Economic burden of chronic bronchitis in the United States: a retrospective case-control studyChristopher M Blanchette
Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC 28081, USA
Int J Chron Obstruct Pulmon Dis 6:73-81. 2011..We examined how this later diagnosis may impact health care costs and utilization during the 12 months prior to and 24 months post initial CB diagnosis...- Adherence to controller therapy for chronic obstructive pulmonary disease: a reviewMeaghan St Charles
Lovelace Respiratory Research Institute, Kannapolis, North Carolina 28081, USA
Curr Med Res Opin 26:2421-9. 2010..The objective of this study was to review data on the outcomes of adherence to various controller therapies in patients with COPD in an effort to help prescribers understand adherence properties for each therapy... 
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage populationChristopher M Blanchette
Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 5127, USA
J Manag Care Pharm 14:176-85. 2008..The economic impact of concomitant asthma and COPD is potentially large but has not been studied...- Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthmaChristopher M Blanchette
Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, North Carolina 287081, USA
Clin Ther 31:2574-83. 2009.... - Comparison between spinal surgery blood transfusion services costs and associated treatment practices in the United States and BelgiumChristopher M Blanchette
Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
Curr Med Res Opin 23:2793-804. 2007..This study assessed utilization and cost of allogeneic blood transfusion (ABT) associated with spinal surgery in the United States (US) and Belgium... - Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPDAnand A Dalal
GlaxoSmithKline, Research Triangle Park, NC, USA
J Med Econ 12:339-47. 2009.... - Relationship between short-acting β2-adrenergic agonist use and healthcare costsHarris S Silver
Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis, NC 28081, USA
Am J Manag Care 17:19-27. 2011..To assess whether increased short-acting β(2)-adrenergic agonist (SABA) claims are associated with asthma exacerbations and increased healthcare costs... - Methylated Genes in Sputum Among Older Smokers With AsthmaAkshay Sood
Department of Medicine, University of New Mexico School of Medicine, NM, USA
Chest 142:425-31. 2012..The epigenetic basis for human asthma is not well studied, particularly among older adults. This study investigated the methylation profiles in sputum DNA among older adults with asthma, using a population of smokers... - Cost and utilization of COPD and asthma among insured adults in the USChristopher M Blanchette
Center for Pharmacoeconomics and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
Curr Med Res Opin 25:1385-92. 2009..This study evaluates the burden of concomitant chronic obstructive pulmonary disease (COPD) + asthma, two highly prevalent and costly conditions... - Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claimsDouglas W Mapel
Lovelace Clinic Foundation, Albuquerque, NM 87106, USA
Int J Chron Obstruct Pulmon Dis 6:573-81. 2011..This study was conducted to determine COPD severity at the time of diagnosis as confirmed by spirometry in patients treated in a US managed care setting... - The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD managementDouglas W Mapel
Lovelace Clinic Foundation, Albuquerque, New Mexico 87106, USA
Prim Care Respir J 19:93-103. 2010..This review focuses on the role of combination ICS/LABA therapy in managing COPD, including indications, potential benefits and considerations that affect therapy decisions... - Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United StatesHarris S Silver
Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA
J Asthma 47:660-6. 2010..The purpose of this study was to determine whether excessive short-acting beta(2)-adrenergic agonist (SABA) dispensed quarterly was associated with asthma exacerbations in the subsequent quarter... - Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patientsAnand A Dalal
US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA
Int J Chron Obstruct Pulmon Dis 5:179-87. 2010..To estimate the cost-effectiveness of fluticasone propionate-salmeterol combination (FSC) compared to salmeterol for maintenance therapy in severe chronic obstructive pulmonary disease (COPD)... - A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging populationChristopher M Blanchette
Center for Pharmacoeconomic and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
Ann Epidemiol 18:316-21. 2008..We assessed the risk of selective serotonin reuptake inhibitor (SSRI) use on the occurrence of acute myocardial infarction (AMI) based on duration of exposure... - Resource utilization and costs of blood management services associated with knee and hip surgeries in US hospitalsChristopher M Blanchette
Premier, Inc. Charlotte, NC, USA
Adv Ther 23:54-67. 2006..30; 95% CI, 2.06-2.57) had a greater likelihood of ABT. Investigators concluded that most transfusion reduction techniques are underused, or they do not reduce the burden of ABT associated with knee or hip surgery... - Economic burden prior to COPD diagnosis: a matched case-control study in the United StatesManabu Akazawa
Department of Health Policy and Administration, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Respir Med 102:1744-52. 2008..To understand the economic burden of COPD prior to diagnosis in the U.S., trends in utilization and costs during the period before initial COPD diagnosis were compared with matched controls... - Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortalityChristopher M Blanchette
Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA
Cardiol Res Pract 2009:194528. 2009..Conclusions. Depression was not associated with time to death or recurrent TCEs in this study. Antidepressant use, including measures of any antidepressant use and SSRI use, was not associated with shorter time to death or recurrent TCE... - Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokersAkshay Sood
University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
Am J Respir Crit Care Med 182:1098-104. 2010..Wood smoke-associated chronic obstructive pulmonary disease (COPD) is common in women in developing countries but has not been adequately described in developed countries... - Cost and utilization of blood transfusion associated with spinal surgeries in the United StatesChristopher M Blanchette
Premier Inc, Pharmaceutical Research Services, Charlotte, NC, USA
Eur Spine J 16:353-63. 2007..Patients that received cell salvage had a lower risk of transfusion (OR=0.40; 95% CI, 0.32-0.50). Most blood avoidance techniques have low utilization or do not reduce the burden of transfusion associated with spinal fusion... - Changes in COPD demographics and costs over 20 yearsChristopher M Blanchette
Department of Public Health Sciences, University of North Carolina, Charlotte, NC 28223, USA
J Med Econ 15:1176-82. 2012..The purpose of this study was to examine the changes in COPD costs over 20 years and assess total direct cost trends over the last 10... - Economic assessment of initial maintenance therapy for chronic obstructive pulmonary diseaseManabu Akazawa
Department of Health Policy and Administration, University of North Carolina at Chapel Hill, USA
Am J Manag Care 14:438-48. 2008.... - Burden of concomitant asthma and COPD in a Medicaid populationFadia T Shaya
Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch St, Twelfth Floor, Baltimore, MD 21201, USA
Chest 134:14-9. 2008..This study compares utilization outcomes in patients with asthma, COPD, or co-occurring asthma and COPD in a Medicaid population, and assesses the incremental burden of COPD in patients with asthma... - Influence of medication treatment patterns on resource use for patients hospitalized for schizophreniaDavid R Strutton
Global Health Outcomes Assessment, Wyeth Research, Collegeville, PA, USA
Am J Health Syst Pharm 65:42-8. 2008..The influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia was studied... - Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimenKaren L Rascati
College of Pharmacy and the Center for Pharmacoeconomic Studies, University of Texas at Austin, Austin, Texas 78712 0127, USA
Clin Ther 29:1203-13. 2007..Limited information is available on the relative outcomes and treatment costs of various pharmacotherapies for chronic obstructive pulmonary disease (COPD) in a Medicaid population... - Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverageLinda Simoni-Wastila
Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore School of Pharmacy, 220 Arch Street, 12th Floor, Baltimore, MD 21201, USA
Health Serv Res 43:496-514. 2008.... - Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid populationFadia T Shaya
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
Arch Intern Med 165:181-6. 2005..This observational cohort study examines the cardiovascular risk of COX-2 inhibitors compared with nonspecific NSAIDs in Maryland Medicaid enrollees, a high-risk population...